Commercially Available Titanium Clip Placement Following a Sonographically Guided Core Needle Biopsy of the Breast
Takayoshi Uematsu
The Breast Journal 13 (6), 624–626
Abstract
Sunday, 18 November 2007
Large Malignant Phyllodes Tumor With Rapid Growth During Pregnancy
Large Malignant Phyllodes Tumor With Rapid Growth During Pregnancy: Images of a Case
Scott A. Simpson BA, Jeremiah Redstone MD, Mohamed S. Aziz MD, Stephanie F. Bernik MD
The Breast Journal 13 (6), 620–621
Abstract
Scott A. Simpson BA, Jeremiah Redstone MD, Mohamed S. Aziz MD, Stephanie F. Bernik MD
The Breast Journal 13 (6), 620–621
Abstract
Apocrine Carcinoma of the Breast: Clinical, Radiologic, and Pathologic Correlation
Apocrine Carcinoma of the Breast: Clinical, Radiologic, and Pathologic Correlation
Ethem Unal MD, Aysun Firat MD, Pembegul Gunes MD, Gamze Kilicoglu MD, Ahmet Gulkilik MD, Izzet Titiz MD
The Breast Journal 13 (6), 617–618
Abstract
Ethem Unal MD, Aysun Firat MD, Pembegul Gunes MD, Gamze Kilicoglu MD, Ahmet Gulkilik MD, Izzet Titiz MD
The Breast Journal 13 (6), 617–618
Abstract
Small Infiltrating Lobular Carcinomas Mimicking Fibroadenoma on Breast MRI
Two Cases of Small Infiltrating Lobular Carcinomas Mimicking Fibroadenoma on Breast MRI
Sachiko Yuen, Takayoshi Uematsu, Masako Kasami
The Breast Journal 13 (6), 616–617
Abstract
The most common features of ILC on MRI are an irregular/spiculated inhomogeneous mass with or without enhancing surrounding small foci, multiple small enhancing foci with interconnecting enhancing strands, and architectural distortion; however, the MR appearances of our cases well reflected one of the intrinsic growth patterns of ILC. Although nonenhancing septation is one of the diagnostic features of fibroadenoma, we should notice that ILC can demonstrate nonenhancing septa on MRI.
Sachiko Yuen, Takayoshi Uematsu, Masako Kasami
The Breast Journal 13 (6), 616–617
Abstract
The most common features of ILC on MRI are an irregular/spiculated inhomogeneous mass with or without enhancing surrounding small foci, multiple small enhancing foci with interconnecting enhancing strands, and architectural distortion; however, the MR appearances of our cases well reflected one of the intrinsic growth patterns of ILC. Although nonenhancing septation is one of the diagnostic features of fibroadenoma, we should notice that ILC can demonstrate nonenhancing septa on MRI.
The Diagnosis and Management of Diabetic Mastopathy
The Diagnosis and Management of Diabetic Mastopathy
Katie Thorncroft, Leigh Forsyth, Sean Desmond, Riccardo A. Audisio
The Breast Journal 13 (6), 607–613
Abstract
Sclerosing lymphocytic lobulitis is strongly associated with type one diabetes, when it is then known as diabetic mastopathy. This very rare benign condition tends to present in premenopausal women, often with diabetic complications particularly retinopathy. Patients present with clinically suspicious fibrous breast lumps; these are commonly multiple, bilateral, and recurrent. Mammograms show asymmetric densities and no focal mass and ultrasound investigation tends to show ill-defined hypoechoic attenuation with strong posterior acoustic shadowing. Magnetic resonance imaging can be used to further differentiate the lesion from malignancy. However, a core biopsy or excisional biopsy is essential so that a pathologic diagnosis can be made. The constellation of pathologic findings is: lymphocytic lobulitis and ductitis with glandular atrophy, lymphocytic/mononuclear perivascular inflammation which is predominantly B-cell and dense often keloid-like fibrosis, with or without epithelioid-like fibroblasts. A review of the current literature on diabetic mastopathy was carried out as it was noted that there has been no recent review of the literature. Detailed Pubmed and other medical data base searches were carried out and all publications were considered, irrespective of language and date, wherever possible
Katie Thorncroft, Leigh Forsyth, Sean Desmond, Riccardo A. Audisio
The Breast Journal 13 (6), 607–613
Abstract
Sclerosing lymphocytic lobulitis is strongly associated with type one diabetes, when it is then known as diabetic mastopathy. This very rare benign condition tends to present in premenopausal women, often with diabetic complications particularly retinopathy. Patients present with clinically suspicious fibrous breast lumps; these are commonly multiple, bilateral, and recurrent. Mammograms show asymmetric densities and no focal mass and ultrasound investigation tends to show ill-defined hypoechoic attenuation with strong posterior acoustic shadowing. Magnetic resonance imaging can be used to further differentiate the lesion from malignancy. However, a core biopsy or excisional biopsy is essential so that a pathologic diagnosis can be made. The constellation of pathologic findings is: lymphocytic lobulitis and ductitis with glandular atrophy, lymphocytic/mononuclear perivascular inflammation which is predominantly B-cell and dense often keloid-like fibrosis, with or without epithelioid-like fibroblasts. A review of the current literature on diabetic mastopathy was carried out as it was noted that there has been no recent review of the literature. Detailed Pubmed and other medical data base searches were carried out and all publications were considered, irrespective of language and date, wherever possible
Cost-Benefit Analysis of a Follow-up Program in Patients with Ca Breast
Cost-Benefit Analysis of a Follow-up Program in Patients with Breast Cancer: A Randomized Prospective Study
Amparo Oltra, A. Santaballa, B. Munarriz, M. Pastor, J. Montalar
The Breast Journal 13 (6), 571–574
Abstract
Increasing the number of breast cancer patients in follow-up involves increased costs and, with limited health care resources, there is a need to evaluate the cost-benefit to the patient of follow-up regimens. We present a randomized prospective study to evaluate the cost-benefit of intensive follow-up in the early detection of relapses in patients with breast cancer. One hundred and twenty-one patients were randomized to standard clinical follow-up (n = 63) or to an intensive follow-up (n = 58) that included diagnostic laboratory tests and imaging designed to detect early relapse following curative treatment. All patients had annual mammography. The number of scheduled outpatient appointments kept were 359 in the standard clinical follow-up and 355 in the intensive follow-up group. After a median of 3 years of follow-up, there were 28 relapses, 11 in standard clinical follow-up, and 13 in the intensive follow-up group. The overall cost of follow-up was 24,567 euros in the standard clinical follow-up group and 74,171 euros in the intensive follow-up group. Performing complimentary investigations in breast cancer follow-up is associated with higher costs without difference in early detection of relapses
Amparo Oltra, A. Santaballa, B. Munarriz, M. Pastor, J. Montalar
The Breast Journal 13 (6), 571–574
Abstract
Increasing the number of breast cancer patients in follow-up involves increased costs and, with limited health care resources, there is a need to evaluate the cost-benefit to the patient of follow-up regimens. We present a randomized prospective study to evaluate the cost-benefit of intensive follow-up in the early detection of relapses in patients with breast cancer. One hundred and twenty-one patients were randomized to standard clinical follow-up (n = 63) or to an intensive follow-up (n = 58) that included diagnostic laboratory tests and imaging designed to detect early relapse following curative treatment. All patients had annual mammography. The number of scheduled outpatient appointments kept were 359 in the standard clinical follow-up and 355 in the intensive follow-up group. After a median of 3 years of follow-up, there were 28 relapses, 11 in standard clinical follow-up, and 13 in the intensive follow-up group. The overall cost of follow-up was 24,567 euros in the standard clinical follow-up group and 74,171 euros in the intensive follow-up group. Performing complimentary investigations in breast cancer follow-up is associated with higher costs without difference in early detection of relapses
BI-RADS MRI Enhancement Characteristics of Ductal Carcinoma In Situ
BI-RADS MRI Enhancement Characteristics of Ductal Carcinoma In Situ
Eric L. Rosen, Stacy A. Smith-Foley, Wendy B. DeMartini, Peter R. Eby, Sue Peacock, Constance D. Lehman
The Breast Journal 13 (6), 545–550
Abstract
Although there is overlap in the MRI morphology and enhancement pattern of in situ and invasive breast carcinoma, DCIS more frequently manifests as NMLE than does invasive carcinoma.
Eric L. Rosen, Stacy A. Smith-Foley, Wendy B. DeMartini, Peter R. Eby, Sue Peacock, Constance D. Lehman
The Breast Journal 13 (6), 545–550
Abstract
Although there is overlap in the MRI morphology and enhancement pattern of in situ and invasive breast carcinoma, DCIS more frequently manifests as NMLE than does invasive carcinoma.
Subscribe to:
Posts (Atom)
